What it is
Regulatory status: dietary supplement; not approved to treat cardiovascular or neurologic disease
Mechanism evidence: human
The combination supplies active folate and B12 forms used in one-carbon metabolism and homocysteine remethylation. Laboratory lowering of homocysteine is not itself proof of improved clinical outcomes.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: dietary supplement; not approved to treat cardiovascular or neurologic disease
Mechanism evidence: human
This is a real two-ingredient product category, not a single molecule. It can address documented nutrient needs, but claims based only on common MTHFR variants or homocysteine targets require individual clinical context.
Confidence: moderate
Known side effects, interactions and use limits from reviewed sources.
The exact strength matters. Folate can obscure blood signs of B12 deficiency, and B12 or folate treatment should not substitute for diagnosing anemia, neuropathy or malabsorption.
This review does not automatically apply to:
Public protocols that include Methylfolate with methylcobalamin. Open one to see the full context and source.
The blend or product stays intact while each known ingredient links to its own reference page.
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
Brand variants reported in public protocols. Private entries are excluded, and inclusion is not an endorsement.
Continue into interventions that appear alongside this one.